These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 2897483

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy.
    Lanas A, Remacha B, Sáinz R, Hirschowitz BI.
    Am J Gastroenterol; 2000 Feb; 95(2):513-9. PubMed ID: 10685760
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Drug therapy of peptic ulcers].
    Fukutomi H, Nakahara A.
    Nihon Naika Gakkai Zasshi; 1991 Jan 10; 80(1):47-54. PubMed ID: 1673704
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of M-cholinolytics and histamine H2 receptor blockaders on the acid-peptide factor in patients with peptic ulcer].
    Masevich TsG, Shastina NN.
    Klin Med (Mosk); 1987 Oct 10; 65(10):73-6. PubMed ID: 2892966
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K, Kato S, Yamamoto H, Okabe S.
    Arzneimittelforschung; 1996 Feb 10; 46(2):177-84. PubMed ID: 8720310
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
    Shamburek RD, Schubert ML.
    Gastroenterol Clin North Am; 1992 Sep 10; 21(3):527-50. PubMed ID: 1355465
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage I-II preparations in the therapy of internal diseases].
    Grebnev AL, Miagkova LP, Kkhorshed AM.
    Klin Med (Mosk); 1991 Mar 10; 69(3):23-7. PubMed ID: 1676772
    [No Abstract] [Full Text] [Related]

  • 15. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases].
    Miagkova LP, Grebenev AL, Kkhorshed AM.
    Klin Med (Mosk); 1991 Mar 10; 69(3):27-34. PubMed ID: 1676773
    [No Abstract] [Full Text] [Related]

  • 16. Drug therapy for preventing peptic ulcer recurrence.
    Sutherland JE.
    Am Fam Physician; 1986 Nov 10; 34(5):141-4. PubMed ID: 2877559
    [Abstract] [Full Text] [Related]

  • 17. [Antagonists of the histamine H2 receptors in the stomach].
    Landa L.
    Gac Med Mex; 1981 Dec 10; 117(12):472-4. PubMed ID: 6123460
    [No Abstract] [Full Text] [Related]

  • 18. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
    Chelvam P, Wong EC.
    J Gastroenterol Hepatol; 1989 Dec 10; 4 Suppl 2():75-81. PubMed ID: 2577478
    [Abstract] [Full Text] [Related]

  • 19. High IgE serum levels and "peptic" ulcers: clinical and functional approach.
    De Lazzari F, Mancin O, Plebani M, Venturi C, Battaglia G, Vianello F, Galliani EA, Di Mario F, Naccarato R.
    Ital J Gastroenterol; 1994 Dec 10; 26(1):7-11. PubMed ID: 7912969
    [Abstract] [Full Text] [Related]

  • 20. Acid reduction in peptic ulcer disease. Choosing therapy according to drug interactions, individual response, and cost.
    Parent K.
    Postgrad Med; 1994 Nov 01; 96(6):53-9. PubMed ID: 7971612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.